Brief: Athenex Announces Agreement With ImmunityBio Regarding Dunkirk Manufacturing Facility

Athenex

12/01/2022 14:13

Jan 12 (Reuters) - Athenex Inc  ATNX.O :
    * ATHENEX ANNOUNCES AGREEMENT WITH IMMUNITYBIO REGARDING
DUNKIRK
MANUFACTURING FACILITY
    * ATHENEX INC - AGREEMENT FOR IMMUNITYBIO,  TO ASSUME ITS
LEASEHOLD INTEREST IN A MANUFACTURING FACILITY IN DUNKIRK, AND
SOME ASSETS FOR ABOUT $38 MILLION
    * ATHENEX INC - IMMUNITYBIO WILL ASSUME ALL CAPITAL
EXPENDITURE
AND HIRING OBLIGATIONS OF ATHENEX PURSUANT TO ITS AGREEMENTS
WITH NEW YORK STATE
    * ATHENEX INC - PROCEEDS FROM SALE WILL BE USED TO SERVICE
COMPANY'S DEBT OBLIGATIONS
    * ATHENEX - IMMUNITYBIO HAS ENTERED INTO A PRELIMINARY
AGREEMENT
WITH ATHENEX TO ALLOW APS ABILITY TO MANUFACTURE ITS 503B
PRODUCTS AT DUNKIRK FACILITY

Source text for Eikon:  ID:nGNX58k8BR 
Further company coverage:  ATNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))